Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

Keyphrases

• High-risk Human Papillomavirus (HR-HPV) 100%
• Proteogenomics 100%
• Head-and-neck Squamous Cell Carcinoma (HNSCC) 100%
• Anti-EGFR Antibody 33%
• Multi-omics Analysis 33%
• Proteomic Analysis 16%
• Monotherapy 16%
• Two-mode 16%
• Immune Infiltration 16%
• Copy number 16%
• Effective Treatment 16%
• Systematic Framework 16%
• Immune Regulation 16%
• Associated Proteins 16%
• CDK Inhibitors 16%
• Phosphoproteomics 16%
• Actin Dynamics 16%
• Dysregulated 16%
• Hot Tumor 16%
• Molecular Subtypes 16%
• Oncogenic Role 16%
• Cold Tumor 16%
• FAT1 16%
• Truncating mutation 16%
• Functional Consequences 16%
• Proteomic Investigation 16%
• Antibody-based Immunotherapy 16%
• Mutual Exclusivity 16%
• EGFR Transactivation 16%
• Phosphosites 16%
• Anti-programmed Cell Death Protein 1 16%
• Immune Checkpoint Molecules 16%
• RNA Processing 16%
• Antibody Therapy 16%
• EGFR Ligands 16%

Biochemistry, Genetics and Molecular Biology

• Epidermal Growth Factor Receptor 100%
• Wart Virus 100%
• Proteogenomics 100%
• Tamsulosin 50%
• Proteomics 50%
• Dynamics 25%
• Carcinogenesis 25%
• Cell Death 25%
• Upregulation 25%
• Synapsin I 25%
• Actin 25%
• Cyclin-Dependent Kinase 25%
• Monoclonal Antibody 25%
• Phosphoproteomics 25%
• Immune Checkpoints 25%
• RNA Processing 25%